CorMedix Inc.
CRMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001410098
No open-market purchases or sales by CorMedix Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $345.5M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 10, 2026
- $418.6M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +7 vs. previous quarter
- 193
- 13F valueReported value at the end of Q2 2026
- $345.5M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $311.7M
- +617.0% year over year
- Net income, FY2025
- $163.1M
- No comparable prior period
- Free cash flow, FY2025
- $172.8M
- No comparable prior period
- Revenue, Q2 FY2026
- $101.9M
- +156.5% year over year
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 14.7M
- Shares sold short
- Change
- −757.0K
- −4.9% vs. previous
- Days to cover
- 12.67
- At average daily volume
Superinvestors holding CRMD, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding CRMD at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by CorMedix Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 22, 2026 (view filing) | Jan 21 | 1 day | Dillione JanetDirector | SSale | −10.0K | $6.88 | −$68.8K | −20.6%38.5K after | 10b5-1 |
| Jan 2, 2026 (view filing) | Dec 30, 2025 | 3 days | Dunton Alan WDirector | SSale | −20.0K | $13.00 | −$260.0K | −33.2%40.3K after | 10b5-1 |
| Dec 19, 2025 (view filing) | Dec 18 | 1 day | Todisco JosephChief Executive Officer | SSale | −30.0K | $12.00 | −$360.0K | −5.6%509.5K after | 10b5-1 |
| Dec 11, 2025 (view filing) | Dec 9 | 2 days | Dillione JanetDirector | SSale | −34.0K | $12.00 | −$408.0K | −41.2%48.5K after | 10b5-1 |
| Dec 10, 2025 (view filing) | Dec 9 | 1 day | Lefkowitz Steven WDirector | SSale | −40.0K | $11.88 | −$475.2K | −33.2%80.5K after | |
| Dec 4, 2025 (view filing) | Dec 2 | 2 days | Dillione JanetDirector | SSale | −46.7K | $10.00 | −$466.6K | −49.0%48.5K after | 10b5-1 |
| Nov 26, 2025 (view filing) | Nov 24 | 2 days | Dillione JanetDirector | SSale | −26.3K | $9.93 | −$261.6K | −35.2%48.5K after | |
| Nov 18, 2025 (view filing) | Nov 14 | 4 days | Dillione JanetDirector | SSale | −30.0K | $11.42 | −$342.6K | −38.2%48.5K after | |
| Oct 27, 2025 (view filing) | Oct 23 | 4 days | Kaplan MyronDirector | PPurchase | +25.0K | $11.02 | +$275.5K | +14.2%201.0K after | |
| Sep 16, 2025 (view filing) | Sep 12 | 4 days | Dunton Alan WDirector | SSale | −10.0K | $13.13 | −$131.3K | −19.9%40.3K after |
Top 10 13F holders, Q2 2026
See all 193 holdersThe largest institutional positions in CorMedix Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6,324,111 | $49.6M | 0.00% | +356,536+6.0% | Added |
| Deep Track Capital, LP | 6,274,076 | $49.3M | 0.73% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 3,135,075 | $24.6M | 0.00% | +5,419+0.2% | Added |
| State Street Corp | 2,316,845 | $18.2M | 0.00% | +125,002+5.7% | Added |
| Royce & Associates LP | 2,176,362 | $17.1M | 0.14% | +288,830+15.3% | Added |
| Geode Capital Management, LLC | 1,947,014 | $15.3M | 0.00% | +130,107+7.2% | Added |
| UBS Group AG | 1,877,940 | $14.7M | 0.00% | +339,695+22.1% | Added |
| Oberweis Asset Management Inc | 1,323,915 | $10.4M | 0.21% | +112,800+9.3% | Added |
| Alyeska Investment Group, L.P. | 850,000 | $6.67M | 0.02% | 00.0% | Unchanged |
| Marshall Wace, LLP | 779,535 | $6.12M | 0.01% | +276,570+55.0% | Added |
Holders of 5% or more of CRMD
See all 3 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of CorMedix Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 13G/A | 7.94%6.27M shares | +1.65 ppfrom 6.29% | Dec 1, 20252 filings | May 15, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 7.50%4.57M shares | – | Feb 5, 20251 filing | Feb 5, 2025 | SEC |
| Shaibatalhamd Aymen Abdalkader | 13G/A | 5.90%4.62M shares | 0.00 ppfrom 5.90% | Apr 4, 20256 filings | Jun 12, 2026 | SEC |